Chest
-
Pulmonary and Sleep MedicineSESSION TYPE: Slide PresentationPRESENTED ON: Saturday, March 22, 2014 at 09:00 AM - 10:00 AMPURPOSE: To evaluate the comparative validity of four prognostic models: pulmonary embolism severity index (PESI), simplified PESI score, PESI risk classes and shock index, for predicting short-term mortality in acute pulmonary embolism. ⋯ The following authors have nothing to disclose: Iulia Cristina Roca, Mihai Roca, Carmen Diana CimpoesuNo Product/Research Disclosure Information.
-
Slide PresentationsPRESENTED ON: Monday, March 24, 2014 at 09:00 AM - 10:00 AMPURPOSE: Biomass smoke exposure is a risk factor for developing chronic obstructive pulmonary disease (COPD). Little is currently known concerning clinical differences between COPD due to tobacco and to biomass smoke. The purpose of this study was to search for clinical differences between both types of disease ⋯ Pilar Sanjuán: Consultant fee, speaker bureau, advisory committee, etc.: Almirall, Astra-Zeneca, Boehringer-Ingelheim Rafael Golpe: Consultant fee, speaker bureau, advisory committee, etc.: Novartis, GSK, Astra-Zeneca, Boehringer-Ingelheim, Almirall Luis Pérez-de-LLano: Grant monies (from industry related sources): Almirall, Consultant fee, speaker bureau, advisory committee, etc.: Almirall, Novertis, Astra-Zeneca, Boehringer-Ingelheim, GSK, Menarini Esteban Cano: Consultant fee, speaker bureau, advisory committee, etc.: GSK Olalla Castro-Añon: Consultant fee, speaker bureau, advisory committee, etc.: NovartisNo Product/Research Disclosure Information.
-
Transplantation PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: Mild hypoxia has been seen in approximately one third of patients with chronic liver disease (CLD). Hepatopulmonary syndrome (HPS) is an important cause in a patient with hypoxemia and CLD. HPS in patients with CLD modifies the line of management and determines the prognosis of the disease. HPS is characterized by arterial de-oxygenation, intrapulmonary vascular dilatation (IPVD) in the setting of liver disease. This study was undertaken to assess the prevalence of HPS and to find predictive value of respiratory parameters in the diagnosis of HPS in patients admitted for liver transplant evaluation. ⋯ The following authors have nothing to disclose: Amrut Sindhu Sanikop, Raj SinghNo Product/Research Disclosure Information.
-
Transplantation PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: Sirolimus, also known as rapamycin, is an immunosuppressant drug introduced in 1999 as prophylaxis or treatment of acute rejection in transplant recipients with other immunosuppressive drugs. In recent years it has been recognized sirolimus-associated pulmonary toxicity with a wide spectrum of clinical pictures within there have been reports of interstitial pneumonitis, diffuse alveolar haemorrhage, and bronchiolitis obliterans organizing pneumonia. ⋯ The following authors have nothing to disclose: Luciana Molinari, Teresita Rosenbaum, Patricia Aruj, Clarisa Alvarez, Cristina Aguirre, Edgardo SobrinoNo Product/Research Disclosure Information.
-
COPD Epidemiology & Physiology PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: COPD exacerbations are important and affects the course of the disease. Clinical trials showed that a subgroup of COPD patients had more exacerbations independent from their FEV1 values and thus a frequent exacerbation subgroup was defined. Small-airway damage has a role for the disease progression of COPD, but the exact relationship between small-airway damage and COPD exacerbations is not entirely clarified. In our study, we investigated the COPD patients who had frequent exacerbations in terms of small airway damage and their difference from patients who had not frequent exacerbations. ⋯ The following authors have nothing to disclose: Yelda Varol, Ceyda Anar, Levent Usta, Gunseli Balci, Rifat OzcacarNo Product/Research Disclosure Information.